Free Republic 3rd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $72,799
89%  
Woo hoo!! And we're now over 89%!! Thank you all very much!! God bless.

Keyword: pneumococcus

Brevity: Headers | « Text »
  • Super-vaccine to guard against all strains of pneumococcal disease (90 strains)

    08/18/2016 12:39:32 PM PDT · by Tilted Irish Kilt · 8 replies
    medicalxpress ^ | August 17, 2016 | Robyn Mills
    Lead researcher James Paton said G-PN would help to increase immune responses to pneumococcus because it kept the antigenic structure of protein surfaces on the bacterium. "Pneumococcus is a big deal in terms of disease and it is the biggest bacterial killer on the planet," he said. "There are currently similar wholesale vaccines being developed, which have used chemical killing but that is nowhere near as good. The fact that gamma radiation is being used to inactivate it makes it a better vaccine.
  • Breast Milk Protein HAMLET Reverses Antibiotic Resistance in MRSA, Pneumococcus

    05/30/2013 12:42:41 PM PDT · by neverdem · 17 replies
    Sci-News.com ^ | May 14, 2013 | Natali Anderson
    According to a new study reported in the open-access journal PLoS ONE, a human breast milk protein complex called HAMLET can help reverse the antibiotic resistance of bacterial species, including penicillin-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus.The image shows a healthy Streptococcus pneumoniae bacterial cell, upper left, next to a bacterial cell destroyed and lysed by the human milk protein complex HAMLET, lower right (Laura R. Marks) In petri dish and animal experiments, HAMLET (Human Alpha-lactalbumin Made Lethal to Tumor Cells) increased bacteria’s sensitivity to multiple classes of antibiotics, such as penicillin and erythromycin.“The effect was so pronounced that bacteria...
  • Vaccine made with synthetic gene protects against deadly pneumonia

    02/22/2011 5:18:40 AM PST · by decimon · 10 replies
    Albert Einstein College of Medicine ^ | February 22, 2011 | Unknown
    Triggers protective immune response while preventing fatal inflammationFebruary 22, 2011 — (BRONX, NY) — Researchers at Albert Einstein College of Medicine of Yeshiva University have developed an experimental vaccine that appears to protect against an increasingly common and particularly deadly form of pneumococcal pneumonia. Details of the new vaccine, which was tested in an animal model, are reported in a paper published today in the Journal of Infectious Diseases. Pneumococcal pneumonia can occur when the lungs are infected with the bacterial species Streptococcus pneumoniae (also known as pneumococcus). "Like many microbes that cause pneumonia, pneumococcus is spread from person to...